Growth Business

NOVEMBER 21, 2023

By Timothy Adler on Growth Business - Your gateway to entrepreneurial success What kind of startups are venture capital trusts (VCTs) looking to invest in during the coming year? However, he points out that VCTs still outperform VCs when it comes to attracting investment by proportion. What kind of startups do VCTs want to invest in?

Investment 59

Investment Capital Business Management 59

Global Newswire by Notified: M&A

OCTOBER 17, 2024

Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand (..)

Pharmaceutical 45

Pharmaceutical Investment Banking Healthcare Bank 45

Global Newswire by Notified: M&A

NOVEMBER 20, 2023

20, 2023 (GLOBE NEWSWIRE) -- Vironova BioAnalytics, a leading provider of transmission electron microscopy (TEM) services, is pleased to announce its acquisition led by QuatreLab (a quality control company created by Columbus Venture Partners) with the participation of Accord Investment Partners and Venture Targeter AB.

Pharmaceutical 40

Pharmaceutical IT Electronics Manufacturing 40

Private Equity Info

JUNE 9, 2025

Yet, behind the scenes, it’s one of the most active areas of investment , particularly over the past two years. PE firms investing in domestic companies. Investments in this area reflect growing demand for minimally invasive technologies, digital health tools, and aging population care.

Private Equity 52

Private Equity Equities Manufacturing Medical 52

Focus Investment Banking

OCTOBER 20, 2023

Washington, DC, (October 20, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that Bearing Distributors, Inc.

Investment Banking 52

Investment Banking Sale Banking Bank 52

The Deal

JUNE 28, 2023

Feldman recently spoke to the Activist Investing Today podcast about “vote no” campaigns in Canada and why insurgent investors in many cases have an advantage if they target companies north of the border. The post Activist Investing Today: Feldman Talks ‘Vote No,’ Canada Rules, Starboard at Ritchie appeared first on The Deal.

Investment 52

Investment Shares Pharmaceutical Investors 52

Growth Business

MAY 31, 2023

By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success According to research from Beauhurst , the first quarter of 2022 was the top performing equity investment quarter on record, with £7.28bn invested into UK start-ups. Angel investment was the third biggest contributor of this investment.

Investment 96

Investment Investors Funds Business 96

Global Newswire by Notified: M&A

AUGUST 15, 2023

Increasing investments of different pharmaceutical and cosmetic companies is a key factor driving 3D printing medical devices market revenue growth. Increasing investments of different pharmaceutical and cosmetic companies is a key factor driving 3D printing medical devices market revenue growth.

Medical 40

Medical Pharmaceutical Investment 40

Global Newswire by Notified: M&A

NOVEMBER 7, 2023

Increasing investments in research and development activities in the pharmaceutical & biotechnology sector and increasing use of mice model for personalized drug production are driving the mice model market.

Pharmaceutical 40

Pharmaceutical Investment 40

Software Equity Group

AUGUST 20, 2024

This opens the door to significant investment and acquisition opportunities for SaaS companies from strategic buyers within and outside of the software industry. The company has made 312 investments since its founding in 1996. Cisco has made 312 investments throughout its 40-year history, including 11 SaaS purchases in 2023.

Investment 52

Investment Management Acquisitions Business 52

OfficeHours

JANUARY 26, 2024

That hadn’t previously been the case since 2009 and highlights how falling valuations and tighter credit markets have forced firms to keep assets for longer than typical five-year investment cycles. They need to invest remaining capital and go back to the market to raise new funds, which means a need to drive exits and improve distributions.”

Private Equity 130

Private Equity Equities Mergers and Acquisitions M&A 130

CNBC: Investing

JUNE 9, 2025

Cardinal Health Josh — All three major Pharmaceutical Wholesalers made the list - McKesson (MCK) , Cencora (COR) and Cardinal Health (CAH) , only Cardinal looks good technically right now: CAH held its 50-day on a weekly closing basis during the April bloodbath, I'd use that area as a stop and update it each week.

Healthcare 59

Healthcare Stock S&P Pharmaceutical 59

Global Newswire by Notified: M&A

JULY 30, 2023

The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding. where they planned to invest more than US$ 50 million in expanding their global bioproduction capabilities. The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding.

Pharmaceutical 40

Pharmaceutical Medical Manufacturing Investment 40

Global Newswire by Notified: M&A

FEBRUARY 28, 2024

This market's growth is underpinned by various factors, most notably the substantial investments pouring into research and development endeavors within the biotechnology and pharmaceutical sectors. SkyQuest projects that the global fetal bovine serum market will attain a value of USD 4.52 billion by 2030, with a CAGR of 14.1%

Pharmaceutical 40

Pharmaceutical Investment 40

Global Newswire by Notified: M&A

FEBRUARY 5, 2025

LONDON and BOSTON and TUSTIN, Calif., LONDON and BOSTON and TUSTIN, Calif.,

Capital 40

Capital Private Equity Healthcare Pharmaceutical 40

Global Newswire by Notified: M&A

JANUARY 14, 2025

Inmar retains and continues investing in its pharmaceutical reverse distribution business, including Rx Returns and Rx Recalls.

Healthcare 40

Healthcare Pharmaceutical Business Investment 40

Global Newswire by Notified: M&A

FEBRUARY 21, 2024

The global Animal Model market size is expected to reach USD 4.44 billion by 2031 and exhibit a CAGR of 7.8% in the forecast period (2024−2031), according to Skyquest's latest research report. The global Animal Model market size is expected to reach USD 4.44 billion by 2031 and exhibit a CAGR of 7.8%

Pharmaceutical 40

Pharmaceutical Engineering Investment 40

Cooley M&A

OCTOBER 19, 2022

Atlas Receives Strategic Investment From Sixth Street Growth. Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals. Sixth Street Invests in Blueprint Medicines. Notable private deals. Thoma Bravo to Sell Frontline Education to Roper Technologies. TCGplayer Agrees to Sell to eBay. DigitalOcean Agrees to Buy Cloudways.

M&A 69

M&A Initial Public Offering Pharmaceutical Medical 69

InvestmentBank.com

AUGUST 14, 2019

The benefits of VR are not limited to language immersion, architecture, interior design, space expedition, biology, chemistry or pharmaceutical practices. With 813 new EdTech companies funded in 2017, the market projects 17% growth in the EdTech industry reaching $250 billion of market investment by 2020 [13]. from China with $1.7

Education 52

Education Mergers and Acquisitions Capital Investment 52

Wizenius

JUNE 28, 2023

Pharmaceutical Sector: In the pharmaceutical industry, growth rates can be influenced by factors like patent expirations, drug pipelines, and regulatory approvals. Companies like Pfizer and Johnson & Johnson have faced this challenge but have strategically invested in R&D and acquisitions to sustain growth.

DCF 52

DCF Financial Modeling Financial Models Discounted Cash Flow 52

Peak Frameworks

SEPTEMBER 12, 2023

A prime example is the pharmaceutical industry. When a new drug hits the market, years of R&D investments need recouping. They are more inclined to invest in cutting-edge products or services, viewing them as a way to differentiate themselves. Setting a High Initial Price Why would a company opt for a high initial price?

Pharmaceutical 52

Pharmaceutical Investment Banking Investment IT 52

The Risk Arbitrage Report

NOVEMBER 20, 2022

New Deals: • Indivior Plc Com (IZQVF) to acquire Opiant Pharmaceuticals Inc Com (OPNT). Morningside Venture Investments & J. . Morningside Venture Investments & J. Washington Federal Inc Com (WAFD) to acquire Luther Burbank Corporation Com (LBC). Sh 11/15/22 (CSVI). Sh 11/15/22 (ECOM). Sh Cad 11/15/22 (NEXJF).

Pharmaceutical 40

Pharmaceutical Acquisitions Corporation Capital 40

Peak Frameworks

AUGUST 15, 2023

If you're interested in breaking into finance, check out our Private Equity Course and Investment Banking Course , which help thousands of candidates land top jobs every year. They can access financial statements and other company details to make informed decisions about their investments. of Apple’s outstanding shares.

Shares 52

Shares Financial Statement Stock Corporation 52

Global Newswire by Notified: M&A

SEPTEMBER 12, 2024

Additionally, the market is growing due to rising investments in healthcare, which are supported by major players in the industry that concentrate on new launches, growing telepathology adoption, and a growing emphasis on precision medicine and drug discovery. By type , the market is segmented into human pathology and veterinary pathology.

Healthcare 40

Healthcare Hospitality Pharmaceutical Management 40

Peak Frameworks

APRIL 29, 2024

If you're interested in breaking into finance, check out our Private Equity Course and Investment Banking Course , which help thousands of candidates land top jobs every year. Capital Requirements The need for substantial capital investment to enter an industry acts as a significant deterrent to new entrants.

Finance 52

Finance Finance Investment Banking Investment 52

Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 2019 was a banner year for billion-dollar life sciences M&A transactions.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

How2Exit

MARCH 31, 2024

This episode serves as a deep dive into Patrick's journey from a young accounting graduate to a M&A powerhouse, navigating transactions in industries as varied as HVAC and pharmaceuticals. Yet, many smaller businesses shy away from this path due to perceived complexities or resources required to execute such a strategy successfully.

Business 130

Business Mergers and Acquisitions Securities M&A 130

Peak Frameworks

SEPTEMBER 18, 2023

Consider a pharmaceutical giant like Pfizer , which imports raw materials for its drugs. If you're interested in breaking into finance, check out our , Private Equity Course and , Investment Banking Course , which help thousands of candidates land top jobs every year.

Private Equity 52

Private Equity Negotiation Valuation Transportation 52

Mergers and Inquisitions

NOVEMBER 1, 2023

They do not invest in risky biotech startups attempting to cure cancer (at least not within their traditional PE portfolios). These firms lie in the territory of life science venture capital firms that invest in high-risk, early-stage companies. Some PE firms also invest in this vertical, typically via separate groups (see below).

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Peak Frameworks

SEPTEMBER 19, 2023

For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Big pharma dominated life sciences M&A, with more than two-thirds (69%) of M&A investment coming from big pharma, compared to just 38% in 2022.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Growth Business

OCTOBER 2, 2023

By Tim Bird on Growth Business - Your gateway to entrepreneurial success It was a buoyant 2018 for venture capital investment into UK and European companies – a trend which defied broader concerns about international trade tensions, economic growth prospects and, of course, Brexit.

Finance 52

Finance Finance Capital Funds 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Focus Investment Banking

JULY 8, 2024

He was the guy who took over a small company, Turing Pharmaceuticals, and raised the price of the life-saving drug, Daraprim, from $13.50 Wendy’s was on the defensive for a bit and offered $1 hamburgers to distract consumers, but they are still going ahead with their investments and plans to implement dynamic pricing in 2025.

Hospitality 40

Hospitality Entertainment Pharmaceutical Sale 40

Solganick & Co.

SEPTEMBER 2, 2024

TPG, a leading global alternative asset management firm, will invest in Aareon with CDPQ, a global investment group, who will co-invest alongside TPG for a minority interest in Aareon. per share in cash in a transaction that values the Company at approximately $1.25 billion.

Mergers and Acquisitions 52

Mergers and Acquisitions Acquisitions Mergers M&A 52

Cooley M&A

FEBRUARY 8, 2018

Second, the FTC continues to aggressively target pharmaceutical companies in connection with mergers and acquisitions. CFIUS’ actions in this regard have led parties to other transactions to abandon their proposed investments.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

Growth Business

MARCH 26, 2025

Similarly, pharmaceutical giant Sandoz demonstrated how creating a psychologically safe environment boosted trust: during a six-week initiative focused on individual engagement, employee willingness to communicate openly increased by 12 per cent.

Business 52

Business Accountant IT Management 52